Search filters

List of works by Dror Michaelson

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC).

scientific article

ASCO 2006 highlights: targeted therapy for renal cell carcinoma.

scientific article published on 23 March 2007

Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisone.

scientific article published in August 2007

Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.

scientific article published in August 2008

Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer

scientific article

Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1).

scientific article

Assessment of progression-free survival as a surrogate end-point for overall survival in patients with metastatic renal cell carcinoma.

scientific article published on 23 April 2014

Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes

scientific article published on 07 September 2020

Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial

scientific article

Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma.

scientific article published on 12 January 2012

Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.

scientific article

Case records of the Massachusetts General Hospital. Case 28-2006. A 59-year-old man with masses in both kidneys

scientific article published on 01 September 2006

Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma

scientific article

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

scientific article published on 2 July 2007

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma.

scientific article

Combination of targeted agents in metastatic renal cell carcinoma: a path forward or a dead-end street?

scientific article published on 06 September 2011

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

scientific article

Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectroscopy.

scientific article

Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes

scientific article published on 22 June 2020

Five-year survival in patients with cytokine-refractory metastatic renal cell carcinoma treated with axitinib.

scientific article published on 4 February 2013

Genitourinary malignancies

scientific article published on 01 January 2003

Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma

scientific article

Importance of Fibroblast Growth Factor Receptor in Neovascularization and Tumor Escape from Antiangiogenic Therapy

scientific article published on February 28, 2012

Kidney cancer

scientific article published on 01 September 2011

Kidney cancer, version 2.2014.

scientific article

Kidney cancer, version 3.2015.

scientific article published on February 2015

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

scientific article published on 22 October 2015

Long-term bisphosphonate treatment of bone metastases from renal cell carcinoma.

scientific article published in October 2004

Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma.

scientific article published in September 2008

Medical oncology consultation and minimization of overtreatment in men with low-risk prostate cancer.

scientific article published on 7 January 2014

Models of care and NCCN guideline adherence in very-low-risk prostate cancer.

scientific article

Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.

scientific article

Multitargeted Tyrosine Kinase Inhibition Produces Discordant Changes Between99mTc-MDP Bone Scans and Other Disease Biomarkers: Analysis of a Phase II Study of Sunitinib for Metastatic Castration-Resistant Prostate Cancer

scientific article published on September 14, 2012

NCCN clinical practice guidelines in oncology: kidney cancer

article

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

scientific article (publication date: August 2009)

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma

scientific article published on 08 June 2015

Phase II study of single-agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen

scientific article published on 25 June 2014

Phase II study of sunitinib in men with advanced prostate cancer.

scientific article

Predictive Markers in Advanced Renal Cell Carcinoma

scientific article published on August 1, 2013

Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer

scientific article published on 15 March 2014

Prognostic significance of indeterminate lung nodules in renal cell carcinoma

scientific article published on 04 January 2014

Prostate cancer (metastatic)

scientific article published in November 2003

Prostate cancer (metastatic).

scientific article

Prostate cancer: metastatic

scientific article published on 01 December 2002

Prostate cancer: metastatic.

scientific article

Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α

scientific article published on May 8, 2012

Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer

scientific article published on 17 July 2014

Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.

scientific article

Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer

scientific article published on 01 August 2006

Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer.

scientific article

Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid

scientific article published on 01 December 1997

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients

scientific article

The role of bisphosphonates in the management of metastatic prostate cancer.

scientific article

Transitional cell carcinoma of the upper uroepithelial tract

scientific article published on 01 February 2003

Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study.

scientific article

Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy

scientific article published on 06 June 2012

Use of an arterial tourniquet to achieve complete radiofrequency ablation of a renal metastasis.

scientific article published on June 2006